Melanoma Breakthroughs: Immunotherapy, ROR2, and Ozuriftamab Vedotin
Groundbreaking research presented at ASCO with Dr. Elinor Barsh, MD, and Dr. Jacob Keeling, MD, focuses on advances in immunotherapy for CTLA-4 resistant melanoma. This episode highlights the importance of…
